3,4-Methylenedioxy-N-ethylamphetamine
3,4-Methylenedioxy-N-ethylamphetamine[edit | edit source]
3,4-Methylenedioxy-N-ethylamphetamine (MDEA) is a synthetic entactogen of the amphetamine class. It is chemically related to MDMA and MDA, and is known for its psychoactive effects. MDEA is commonly referred to as "Eve" in the context of recreational use.
Chemical Structure and Properties[edit | edit source]
MDEA is a member of the phenethylamine and amphetamine chemical classes. Its chemical structure consists of a methylenedioxy ring attached to the phenyl group, with an ethyl group attached to the nitrogen atom of the ethylamine chain. This structure is similar to that of MDMA, with the primary difference being the ethyl group in place of the methyl group.
Pharmacology[edit | edit source]
MDEA acts primarily as a serotonin-norepinephrine-dopamine releasing agent (SNDRA). It increases the levels of these neurotransmitters in the brain, leading to its psychoactive effects. The entactogenic effects of MDEA are attributed to its action on the serotonin system, similar to other drugs in the MDxx family.
Effects[edit | edit source]
The effects of MDEA are similar to those of MDMA, though generally considered to be less intense. Users report feelings of euphoria, increased sociability, and enhanced sensory perception. The duration of effects typically lasts 3 to 6 hours, with a peak occurring around 1 to 2 hours after ingestion.
Synthesis[edit | edit source]
MDEA can be synthesized from safrole, a precursor also used in the synthesis of MDMA and MDA. The synthesis involves several chemical reactions, including the formation of the methylenedioxy ring and the attachment of the ethylamine chain.
Legal Status[edit | edit source]
MDEA is classified as a Schedule I controlled substance in many countries, including the United States, under the Controlled Substances Act. This classification indicates that it is considered to have a high potential for abuse and no accepted medical use.
Related Compounds[edit | edit source]
- MDMA (3,4-Methylenedioxy-N-methylamphetamine)
- MDA (3,4-Methylenedioxyamphetamine)
- MBDB (3,4-Methylenedioxy-N-methylbutanamine)
Related Pages[edit | edit source]
Gallery[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD